AbbVie Executive and Leadership Team

Virginia Lavery, the Chief Financial Officer at AbbVie, directs all financial operations and strategic financial planning for the global biopharmaceutical company. This critical role involves managing capital allocation, investor relations, and ensuring the financial health of the organization as it pursues innovative treatments for complex medical challenges. Lavery's responsibilities encompass overseeing budgeting, forecasting, and financial reporting, providing essential insights that guide AbbVie's investment in research and development across its core therapeutic areas, including immunology, oncology, and neuroscience. The Chief Financial Officer's strategic guidance is paramount in supporting AbbVie's commitment to improving patient outcomes and quality of life through groundbreaking therapies. Virginia Lavery's financial acumen underpins the company's ability to sustain its operations and expand its reach in addressing unmet medical needs worldwide.

Itamar Seindlis, the Director, Finance & Chief Financial Officer at AbbVie, manages key financial operations and contributes to strategic financial planning for the biopharmaceutical company. This role supports AbbVie's dedication to developing innovative health solutions for complex medical challenges. Seindlis's responsibilities include overseeing financial reporting, budgeting, and analysis, providing critical data to guide investment decisions in therapeutic areas like neuroscience and eye care. The Chief Financial Officer's financial oversight is essential for sustaining AbbVie's research and development efforts aimed at improving patient outcomes and quality of life. Itamar Seindlis's financial expertise ensures the efficient allocation of resources, enabling AbbVie to pursue groundbreaking therapies and maintain its leadership in addressing unmet medical needs globally.

Jeanne Martinez, the Regional Chief Financial Officer at AbbVie, oversees financial operations and strategic planning for specific geographic regions, ensuring alignment with the company's global objectives. This executive role is vital for supporting AbbVie's mission of delivering innovative medicines and health solutions across diverse markets. Martinez's responsibilities include managing regional budgets, financial performance analysis, and driving financial efficiency to support AbbVie's therapeutic focus areas, such as immunology and oncology. The Regional Chief Financial Officer plays a key part in optimizing resource allocation to advance treatments that improve patient outcomes and quality of life. Jeanne Martinez's financial leadership ensures that AbbVie's regional operations effectively contribute to addressing complex medical challenges and expanding access to vital therapies worldwide.

Hiroyuki Kojima, the Chief of Staff at AbbVie, directs strategic initiatives and operational alignment across key departments. This leadership position involves facilitating communication between executive leadership and various functional teams, ensuring seamless execution of corporate objectives. Kojima's oversight extends to managing critical projects that support AbbVie's mission of discovering and delivering innovative medicines. The role requires a deep understanding of the biopharmaceutical landscape, enabling effective coordination of efforts in areas such as immunology, oncology, and neuroscience. By streamlining internal processes and fostering collaboration, Hiroyuki Kojima enhances the company's capacity to address complex medical challenges and improve patient outcomes globally. This executive's focus is on optimizing organizational efficiency to accelerate therapeutic advancements.

Brian Szopinski, the Director, Clinical Operations & Chief of Staff at AbbVie, spearheads the execution of clinical trials and provides strategic operational support to executive leadership. This dual role demands meticulous management of clinical operations, ensuring adherence to regulatory standards and efficient progression of studies across AbbVie's therapeutic areas. Szopinski's responsibilities include optimizing trial design, site management, and data collection processes, directly contributing to the development of innovative medicines for complex diseases. As Chief of Staff, Brian Szopinski facilitates cross-functional collaboration, ensuring alignment between clinical development teams and the broader organizational strategy. This leadership ensures that AbbVie's efforts to improve patient outcomes and quality of life are supported by robust and efficient clinical execution. The Director's focus is on driving operational excellence within clinical research.

Donald Wyma, the Chief of Staff, Oncology Discovery at AbbVie, drives strategic alignment and operational efficiency within the company's oncology research and development initiatives. This pivotal role involves coordinating efforts across discovery teams, ensuring that scientific advancements translate into potential new therapies for cancer patients. Wyma's responsibilities include facilitating communication, managing key projects, and supporting the strategic direction of oncology drug discovery. The Chief of Staff's focus is on accelerating the development pipeline, addressing significant unmet medical needs in oncology. Donald Wyma's leadership ensures that AbbVie's commitment to innovation in cancer treatment is effectively supported by streamlined operations and strategic resource allocation, ultimately aiming to improve patient outcomes and quality of life in this critical therapeutic area.

Valerie Menaker, the Director, Strategic Operations & Oncology Early Development Operations Chief of Staff at AbbVie, orchestrates critical operational strategies for early-stage oncology development. This role is central to advancing AbbVie's pipeline of innovative treatments for complex cancers. Menaker's responsibilities include enhancing operational efficiency, managing strategic projects, and ensuring seamless execution of early development activities within the oncology portfolio. As Chief of Staff, Valerie Menaker provides essential support to leadership, fostering collaboration and driving progress towards key milestones. This executive's work directly impacts AbbVie's ability to deliver life-changing therapies, addressing significant unmet medical needs and improving patient outcomes. The Director's focus is on optimizing the operational framework for groundbreaking oncology research.

Patricia T., the Director, Chief Information Officer and Technology Communications at AbbVie, leads the strategic direction and communication initiatives for the company's information technology infrastructure. This role is crucial for ensuring that technology solutions effectively support AbbVie's mission of discovering and delivering innovative medicines. Patricia T.'s responsibilities include overseeing IT operations, managing technology communications, and aligning technology strategies with the company's broader business objectives in areas like immunology, oncology, and neuroscience. The Chief Information Officer ensures robust and secure IT systems that facilitate research, development, and global operations. This leadership drives the effective use of technology to enhance patient outcomes and improve overall quality of life by supporting AbbVie's commitment to addressing complex medical challenges.

Mark Schacher, the Director, Data and Statistical Science and Chief of Staff at AbbVie, directs the application of advanced data analytics and statistical methodologies to support drug discovery and development. This role is integral to AbbVie's commitment to delivering innovative medicines by leveraging data-driven insights. Schacher's responsibilities include overseeing statistical analysis for clinical trials, managing data science initiatives, and ensuring the integrity and interpretability of scientific data. As Chief of Staff, Mark Schacher provides strategic operational support, facilitating collaboration across research teams and ensuring alignment with corporate objectives. This leadership enhances AbbVie's capacity to address complex medical challenges and improve patient outcomes through rigorous scientific analysis and efficient operational coordination.

Mark Stahl, the Vice President, Information Technology & Chief Information Officer at AbbVie, directs the company's global information technology strategy and operations. This executive leadership role is fundamental to supporting AbbVie's mission of discovering and delivering innovative medicines that address complex health challenges. Stahl's responsibilities encompass managing IT infrastructure, cybersecurity, digital transformation initiatives, and ensuring technology solutions align with the company's research and development goals in areas such as immunology and oncology. The Chief Information Officer's oversight ensures that AbbVie has the technological capabilities necessary to drive scientific advancement and improve patient outcomes. Mark Stahl's strategic vision for IT enhances operational efficiency and supports AbbVie's commitment to improving the quality of life for patients worldwide.